Page 3 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech Today - Breaking & Trending Today

Biopharma Stock Breaking News - BioNTech (Nasdaq: BNTX) and DualityBio Receive FDA Fast Track Designation

Biopharma Stock Breaking News - BioNTech (Nasdaq: BNTX) and DualityBio Receive FDA Fast Track Designation ....

United States , Fosun Pharma , Vivian Gu , Roche Group , Duality Biologics Suzhou Co Ltd , Exchange Commission , Business Development , Drug Administration , Duality Biologics , Fast Track , Chief Medical Officer , Duality Immune Toxin Antibody Conjugates , New Technologies , Antibody Drug Conjugate , Private Securities Litigation Reform Act , Pract Res Clin Obstet , Investor Ideas , Fda Fast Track Designation ,

Bragar Eagel & Squire, P.C. Reminds Investors That Class

NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that. ....

New York , United States , South Carolina , Bragar Eagel Squire , Marion Passmore , Brandon Walker , Mercury Systems Inc , Tesla Inc , Optics Corporation , Drug Administration , Office Of Scientific Investigations , Biovie Inc , Semiconductor Corporation , Glasshouse Research , Mercury Systems , Plaintiff Deadline , Physical Optics Corporation , Class Period , Mercury System , Common Stock Only , Good Clinical Practice , Scientific Investigations , Defendant Phase , Bragar Eagel , Bragar Eagel Amp Squire , Mercury Systems ,

Projectmates Construction Program Management Software Wins

Constructech Recognizes Projectmates Software as a 2024 Trusted Product. ....

United States , Peggy Smedley , Varsha Bhave , Developers At Projectmates , Systemates Inc , Constructech Top Product , Chief Technology Officer , Top Product , Specialty Publishing , Constructech Top Products , Nasdaq Stockholm , Projectmates By Systemates , Construction Technology , Construction Projects ,

BioNTech challenges AstraZeneca with breast cancer precision drug trial

BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo. COVID-19 vaccine maker BioNTech, which is renewing its focus on its traditional roots in oncology, said in a joint statement with China's Duality that their drug would be tested on women with a certain type of advanced breast cancer with low levels of a cell surface receptor known as HER2. Partners Astra and Daiichi have taken the concept further with their leading drug Enhertu, based on the antibody-drug conjugate technology, a type of high-precision chemotherapy. ....

Ludwig Burger , Daiichi Sankyo , Roche Herceptin , Duality Biologics , Partners Astra , Louise Heavens , Breast Cancer , Advanced Breast Cancer , Daiichi Sankyo , Duality Biologics , Ell Surface Receptor ,

Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook

Market forces rained on the parade of BioNTech SE ( NASDAQ:BNTX ) shareholders today, when the analysts downgraded. ....

Revenue Estimates , Arnings Per Share , Price Target , Revenue Decline ,